Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Leucanthemum vulgare
Common European meadow daisy used in folk medicine for respiratory conditions, wounds, and menstrual disorders.
Ox-Eye Daisy (Leucanthemum vulgare) is a European meadow daisy traditionally used for respiratory conditions, wound healing, and menstrual disorders. Its primary active compounds include luteolin, apigenin, chrysanthemol, tannins, and bitter glycosides, which contribute to its antispasmodic, anti-inflammatory, and antitussive properties. Evidence level C indicates limited clinical studies support these uses.
The flavonoids luteolin and apigenin inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, thereby exerting anti-inflammatory effects. Chrysanthemol and bitter glycosides may stimulate bitter taste receptors (TAS2Rs) in the respiratory tract, leading to increased mucus secretion and antitussive action. Tannins provide astringent and wound-healing properties by precipitating proteins and forming a protective barrier on mucous membranes and skin.
Common European meadow daisy used in folk medicine for respiratory conditions, wounds, and menstrual disorders.
Ox-Eye Daisy (Leucanthemum vulgare) is a European meadow daisy traditionally used for respiratory conditions, wound healing, and menstrual disorders. Its primary active compounds include luteolin, apigenin, chrysanthemol, tannins, and bitter glycosides, which contribute to its antispasmodic, anti-inflammatory, and antitussive properties. Evidence level C indicates limited clinical studies support these uses.
The flavonoids luteolin and apigenin inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, thereby exerting anti-inflammatory effects. Chrysanthemol and bitter glycosides may stimulate bitter taste receptors (TAS2Rs) in the respiratory tract, leading to increased mucus secretion and antitussive action. Tannins provide astringent and wound-healing properties by precipitating proteins and forming a protective barrier on mucous membranes and skin.